JPRN-UMIN000022109尚未招募未知
Effect of Empagliflozin on Ambulatory Blood Pressure Monitoring (ABPM) - Effect of Empagliflozin on ABPM
Department of General Internal Medicine, Saitama Medical University0 个研究点目标入组 20 人开始时间: 2018年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •eGFR<30ml/min/1.73m2 Liver Dysfunction
研究者
相似试验
尚未招募
不适用
Effect of dapagliflozin on blood pressure, cardiac function, visceral fat in type 2 diabetes mellitus patients with hypertension.type 2 diabetesJPRN-UMIN000015203Takeda Hospital Medical Examination Center30
已完成
不适用
Tofogliflozin Reduces 24-h Ambulatory Blood Pressure in inpatients with Type 2 Diabetes and HypertensioType 2 diabetes with hypertensionJPRN-UMIN000022580Dokkyo Medical University20
进行中（未招募）
1 期
Effect of dapagliflozin on nighttime blood pressure in type 2 diabetesPatients with diabetes and high blood pressureMedDRA version: 20.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-002125-38-ESM Diagnósticos S.L.225
招募中
3 期
Effect of empagliflozin on blood pressure, cardiovascular events, mortality and renal parametersIRCT20190911044744N3Yazd University of Medical Sciences50
招募中
不适用
Evaluation of the effect of Empagliflozin on blood glucose, BMI, HbA1c and insulin dose in patients with type 1 diabetesType 1 diabetes mellitusIRCT20130610013612N12Tabriz University of Medical Sciences60